A detailed history of Sentinel Trust CO Lba transactions in Novo Nordisk A S stock. As of the latest transaction made, Sentinel Trust CO Lba holds 44,172 shares of NVO stock, worth $4.49 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
44,172
Previous 44,172 -0.0%
Holding current value
$4.49 Million
Previous $6.31 Million 16.57%
% of portfolio
0.6%
Previous 0.78%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $2.08 Million - $4.57 Million
22,922 Added 107.87%
44,172 $4.02 Million
Q1 2023

May 05, 2023

BUY
$132.34 - $159.14 $2.81 Million - $3.38 Million
21,250 New
21,250 $3.38 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sentinel Trust CO Lba Portfolio

Follow Sentinel Trust CO Lba and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentinel Trust CO Lba, based on Form 13F filings with the SEC.

News

Stay updated on Sentinel Trust CO Lba with notifications on news.